In a phase 3 open-label study in healthy adults, single-dose sublingual epinephrine film (AQST-109) met primary PK bracketing vs intramuscular epinephrine, EpiPen and Auvi-Q, with median time to peak concentration 12 min vs 20-50 min. No serious adverse events.
RCT
Golden et al. Pharmacokinetics and pharmacodynamics of AQST-109: Phase 3 results comparing epinephrine sublingual film with intramuscular injection